Geneva, April 20 -- International Clinical Trials Registry received information related to the study (KCT0011833) titled 'A Study on the Efficacy and Safety of Early Use of New Cholesterol-lowering Agents (PCSK9 Inhibitors) in Patients after Stent Procedure for Acute Myocardial Infarction' on April 10.
Study Type: Interventional Study
Study Design:
Primary Purpose : Treatment, Intervention Model : Parallel, Blinding/Masking : Open, Allocation : RCT
Primary Sponsor: Hallym University Medical Center-Dongtan
Condition:
Diseases of the circulatory system
Intervention:
Drug : This study compares two lipid-lowering strategies in AMI patients undergoing PCI.
Intervention Group: Triple therapy consisting of once-daily oral rosuvastatin ...